The Scientist

» cancer, microbiology and culture

Most Recent

image: All’s Not Fair in Science and Publishing

All’s Not Fair in Science and Publishing

By | July 1, 2012

False credit for scientific discoveries threatens the success and pace of research.

72 Comments

image: Killer Silk

Killer Silk

By | July 1, 2012

False credit for scientific discoveries threatens the success and pace of research.

4 Comments

image: The Little Cell That Could

The Little Cell That Could

By | July 1, 2012

False credit for scientific discoveries threatens the success and pace of research.

1 Comment

image: Jumping Genes a Cause of Cancer?

Jumping Genes a Cause of Cancer?

By | June 28, 2012

False credit for scientific discoveries threatens the success and pace of research.

2 Comments

image: NIH Tackles Racism

NIH Tackles Racism

By | June 25, 2012

False credit for scientific discoveries threatens the success and pace of research.

2 Comments

image: Nanoparticles Prevent Disease

Nanoparticles Prevent Disease

By | June 22, 2012

False credit for scientific discoveries threatens the success and pace of research.

1 Comment

image: Roundup from Microbiology Meeting

Roundup from Microbiology Meeting

By | June 21, 2012

False credit for scientific discoveries threatens the success and pace of research.

0 Comments

image: A Plea to the FDA

A Plea to the FDA

By | June 21, 2012

False credit for scientific discoveries threatens the success and pace of research.

2 Comments

image: Gene Patents Back in Court

Gene Patents Back in Court

By | June 19, 2012

False credit for scientific discoveries threatens the success and pace of research.

0 Comments

image: UK Gov’t Supports Open Access Plan

UK Gov’t Supports Open Access Plan

By | June 19, 2012

False credit for scientific discoveries threatens the success and pace of research.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech